Abstract:Abstract Objective To characterise and analyse the experiences of trial researchers of if and how conflicts of interest had unduly influenced clinical trials they had worked on, what management strategies they had used to minimise any potential influence, and their experiences and views on conflicts of interest more generally. Design Qualitative interview study. Participants Trial researchers who had participated in at least 10 clinical trials with methodological or statistical expertise. Researchers differed by geographical location, educational background, and experience with different types of funders. Interviewees were identified by searches on Web of Science and snowball sampling. 52 trial researchers were approached by email; 20 agreed to be interviewed. Setting Interviews conducted by telephone, recorded, transcribed verbatim, imported to NVivo 12, and analysed by systematic text condensation. Semistructured interviews focused on financial and non-financial conflicts of interest. Results The interviewees had participated in a median of 37.5 trials and were mainly male physicians who had experience with commercial and non-commercial trial funders. Two predefined themes (influence of conflicts of interest and management strategies) and two additional themes (definition and reporting of conflicts of interest) emerged. Examples of perceived influence of conflicts of interest were: choice of inferior comparator, manipulation of the randomisation process, prematurely stopping the trials, fabrication of data, blocking access to data, and spin (eg, overly favourable interpretation of the results). Examples of strategies to manage conflicts of interest were: disclosure procedures, exclusion of the funder from design and analysis, independent committees, contracts ensuring complete access to the data, and no restriction by the funder on analysis and reporting. Interviewees used different definitions or thresholds for what they considered to be conflicts of interest, and they described different criteria for when to report them. Some interviewees considered non-commercial financial conflicts of interest (eg, funding of trials by governmental health agencies with a political agenda) to be equally or more important than commercial financial conflicts of interest (eg, funding by drug and device companies), but more challenging to report and manage. Conclusion This study described how trial researchers perceive conflicts of interest unduly influencing clinical trials they had worked on, and the management strategies they used to prevent these influences. The results indicated considerable variability in researchers’ understanding of what conflicts of interest are and when they should be reported.

[Immunoenzyme analysis of the change in the expression of class II antigens of the major histocompatibility complex under the influence of interferon preparations].

Policies on doctors' declaration of interests in medical organisations: a thematic analysis

Where do UK clinicians find information at the point of care? A pragmatic, exploratory study

Influence and management of conflicts of interest in randomised clinical trials: qualitative interview study

Effect of revealing authors' conflicts of interests in peer review: randomized controlled trial

Patient experiences of information-sharing and patient-centred care across the broad landscape of primary care practice and provision: a nationally representative survey of Australian adults

The willingness of community pharmacists to participate in a practice-based research network

Professionalism dilemmas, moral distress and the healthcare student: insights from two online UK-wide questionnaire studies

Barriers and best practices to improving clinical trials transparency at UK public research institutions: A qualitative interview study

Treatment of chronic biceps tendon ruptures

Managing conflicts of interest in the development of health guidelines

Is bureaucracy being busted in research ethics and governance for health services research in the UK? Experiences and perspectives reported by stakeholders through an online survey

What do patients and the public know about clinical practice guidelines and what do they want from them? A qualitative study

Confidentiality and public interest disclosure: A framework to evaluate UK healthcare professional regulatory guidance

Public responses to the sharing and linkage of health data for research purposes: a systematic review and thematic synthesis of qualitative studies

Conflict of Interest Disclosure in Oncology: Preliminary Insights From the Global ONCOTRUST-1 Cross-Sectional Study

Potential Conflicts of Interest Arising from Dualism of Loyalty Imposed on Employees of Medical Institutions-Findings and Tools for Ethics Management

Reporting of Declarations and Conflicts of Interest in WHO Guidelines Can Be Further Improved.

Accessibility and transparency of editor conflicts of interest policy instruments in medical journals

What influences a person’s willingness to share health information for both direct care and uses beyond direct care? Findings from a focus group study in Ireland

Requesting conflicts of interest declarations from the European Medicines Agency: 3-year follow-up status